In:
Journal of the Pediatric Infectious Diseases Society, Oxford University Press (OUP), Vol. 12, No. 9 ( 2023-09-27), p. 513-518
Abstract:
We assessed anti-Vi IgG/IgA responses to typhoid conjugate vaccine (TCV) in children enrolled in a double-blind randomized controlled, phase 2 trial in Burkina Faso. Anti-Vi IgG seroconversion and anti-Vi IgA titers were higher in TCV than control recipients at 30–35 months post-vaccination. TCV induces durable immunity in Burkinabe children vaccinated at 15 months.
Type of Medium:
Online Resource
ISSN:
2048-7207
DOI:
10.1093/jpids/piad058
Language:
English
Publisher:
Oxford University Press (OUP)
Publication Date:
2023
detail.hit.zdb_id:
2668791-4
Permalink